We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About PIQUR Therapeutics Stock

Invest in or calculate the value of your shares in PIQUR Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

PIQUR Therapeutics Stock (PITH)

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

About PIQUR Therapeutics Stock

Founded

2011

Total Funding

85.8M

Industries

Software, Artificial Intelligence, Data and Analytics

PIQUR is a Swiss clinical-stage pharmaceutical company incorporated in August 2011 as a spin-off of the University of Basel, focusing on the discovery and development of innovative anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR’s pipeline originates from one of the most promising research areas in oncology. Both PI3K and mTOR are clinically validated drug targets in oncology. PIQUR has a secured patent scope protecting many chemical compounds.

PIQUR Therapeutics Management

Leadership team at PIQUR Therapeutics

Chief Scientific Officer

Doriano Fabbro

Head BD & Communications

Tatsuo Satoh

Locked Features

Join now and verify your accreditation status to gain access to:

  • PIQUR Therapeutics current valuation
  • PIQUR Therapeutics stock price
  • Available deals in PIQUR Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in PIQUR Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like PIQUR Therapeutics through EquityZen funds. These investments are made available by existing PIQUR Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell PIQUR Therapeutics stock?

Shareholders can sell their PIQUR Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."